Novel compounds that are useful for improving pharmacokinetics
申请人:Kempf J. Dale
公开号:US20060199851A1
公开(公告)日:2006-09-07
Novel compounds of formula 1
or a pharmaceutically acceptable salt thereof inhibit cytochrome P450 monooxygenase.
公式1的新化合物或其药用可接受的盐可以抑制细胞色素P450单加氧酶。
2-Substituted-1 H-benzimidazile-4-carboxamides are PARP inhibitors
申请人:Zhu Gui-Dong
公开号:US20060229351A1
公开(公告)日:2006-10-12
Compounds of Formula (I)
inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), method of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compound of Formula (I).
VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING
申请人:Von Geldern Thomas W.
公开号:US20090131379A1
公开(公告)日:2009-05-21
The invention relates to compounds that are vitamin D receptor activators, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.
Penem derivatives and antimicrobial agents containing the same
申请人:SUNTORY LIMITED
公开号:EP0774465A1
公开(公告)日:1997-05-21
Penem derivatives represented by the following Formula (I):
wherein Z represents a hydroxyl group or a fluorine atom, R1 represents a substituted or unsubstituted alkyl, alkenyl, aralkyl group, aryl group, heterocyclic, or acyl group, or a hydrogen atom, and R2 represents a hydrogen atom or a carboxyl-protecting group; and pharmacologically acceptable salts thereof are antibacterial agents effective against, inter alia, methicillin-resistant Staphylococcus aureus. The derivatives and salts are novel except when R1 is ethyl and Z is hydroxyl. The analogous compounds in which R2 is a carboxyl-protecting group and any hydroxyl group represented by Z is protected are novel process intermediates.
A process for forming a cycloalkylidene bisphenol comprises: reacting a cycloalkanone compound of formula:
where [A] is a substituted or an unsubstituted aromatic group, R
1
-R
4
independently represent a hydrogen or a C
1
-C
12
hydrocarbyl group; and “a” and “b” are integers independently having values from 0-3; with an aromatic hydroxy compound of formula [A]-OH, where [A] is as previously described; at a mole ratio of greater than or equal to about 20, in the presence of a sulfonic acid type ion exchange resin catalyst crosslinked with greater than or equal to about 8 weight percent of divinylbenzene, and a promoter selected from the group consisting of a mercaptan compound and a resorcinol compound; to form a cycloalkylidene bisphenol of formula:
where [A], R
1
-R
4
, “a” and “b” are as previously described. Moreover, any acid catalyst can be used with a resorcinol promoter.